drugset / Trial / NCT00646126
Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission
Phase 3
Completed
Tropical Medicine Research Institute
International Atomic Energy Agency · collabLondon School of Hygiene and Tropical Medicine · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry season in areas of seasonal malaria transmission. Targeting this parasite reservoir before the transmission season could be a good strategy for malaria control. We are conducting a randomized double blind placebo controlled mass drug administration trial in eight village to clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in eastern Sudan.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Artesunate | Small molecule | — | — |
| Comparator | pyrimethamine | Small molecule | — | — |
| Comparator | sulfadoxine | Small molecule | — | — |